ClinicalTrials.Veeva

Menu

Clinical Comparison of DDT2 Contact Lens and a Daily Disposable Contact Lens - Study 2

Alcon logo

Alcon

Status

Completed

Conditions

Myopia
Refractive Error

Treatments

Device: Verofilcon A contact lenses
Device: Somofilcon A contact lenses

Study type

Interventional

Funder types

Industry

Identifiers

NCT03888482
CLE383-C010

Details and patient eligibility

About

The purpose of this study was to evaluate visual acuity at distance when wearing DDT2 contact lenses compared to Clariti contact lenses.

Full description

Subjects were expected to attend 3 study visits and wear the DDT2 and Clariti study lenses in a crossover design for approximately 14 - 20 days (7 - 10 days for each product).

Enrollment

154 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Key Inclusion Criteria:

  • Able to understand and sign an Informed Consent Form that has been approved by an Institutional Review Board.
  • Willing and able to attend all scheduled study visits as required per protocol.
  • Current wearer of spherical soft contact lenses.

Key Exclusion Criteria:

  • Any ocular condition that contraindicates contact lens wear.
  • Previous or current habitual wearer of clariti® or DAILIES TOTAL1® contact lenses.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

154 participants in 2 patient groups

DDT2, then Clariti
Other group
Description:
Verofilcon A contact lenses worn first, with somofilcon A contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) for 8 -1/+2 days in a daily disposable modality.
Treatment:
Device: Somofilcon A contact lenses
Device: Verofilcon A contact lenses
Clariti, then DDT2
Other group
Description:
Somofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) for 8 -1/+2 days in a daily disposable modality.
Treatment:
Device: Somofilcon A contact lenses
Device: Verofilcon A contact lenses

Trial documents
2

Trial contacts and locations

8

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems